Brown Advisory Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,583
| Closed | -$351K | – | 63 |
|
|
2022
Q2 | $351K | Hold |
4,583
| – | – | 0.33% | 86 |
|
|
2022
Q1 | $337K | Sell |
4,583
-1,113
| -20% | -$74.7K | 0.2% | 115 |
|
|
2021
Q4 | $351K | Sell |
5,696
-13,181
| -70% | -$773K | 0.15% | 132 |
|
|
2021
Q3 | $1.12M | Sell |
18,877
-9,418
| -33% | -$620K | 0.33% | 70 |
|
|
2021
Q2 | $1.89M | Sell |
28,295
-8,225
| -23% | -$536K | 0.3% | 65 |
|
|
2021
Q1 | $2.31M | Sell |
36,520
-8,863
| -20% | -$551K | 0.39% | 53 |
|
|
2020
Q4 | $2.81M | Buy |
45,383
+717
| +2% | +$44.1K | 0.48% | 45 |
|
|
2020
Q3 | $2.69M | Sell |
44,666
-3,459
| -7% | -$208K | 0.55% | 42 |
|
|
2020
Q2 | $2.79M | Sell |
48,125
-323
| -0.7% | -$19.3K | 0.59% | 38 |
|
|
2020
Q1 | $2.81M | Buy |
48,448
+4,265
| +10% | +$261K | 0.72% | 36 |
|
|
2019
Q4 | $2.84M | Buy |
44,183
+14,262
| +48% | +$817K | 0.68% | 36 |
|
|
2019
Q3 | $1.51M | Buy |
29,921
+17,282
| +137% | +$812K | 0.43% | 56 |
|
|
2019
Q2 | $574K | Sell |
12,639
-1,350
| -10% | -$62.9K | 0.15% | 130 |
|
|
2019
Q1 | $665K | Sell |
13,989
-8,901
| -39% | -$443K | 0.16% | 123 |
|
|
2018
Q4 | $1.2M | Sell |
22,890
-614
| -3% | -$33K | 0.23% | 94 |
|
|
2018
Q3 | $1.46M | Sell |
23,504
-3,160
| -12% | -$188K | 0.23% | 93 |
|
|
2018
Q2 | $1.47M | Buy |
26,664
+1,025
| +4% | +$55.4K | 0.26% | 93 |
|
|
2018
Q1 | $1.62M | Buy |
25,639
+980
| +4% | +$63K | 0.3% | 79 |
|
|
2017
Q4 | $1.51M | Buy |
24,659
+1,903
| +8% | +$119K | 0.29% | 85 |
|
|
2017
Q3 | $1.45M | Buy |
22,756
+2,756
| +14% | +$161K | 0.31% | 78 |
|
|
2017
Q2 | $1.11M | Buy |
20,000
+918
| +5% | +$50K | 0.25% | 96 |
|
|
2017
Q1 | $1.04M | Sell |
19,082
-4,141
| -18% | -$227K | 0.26% | 97 |
|
|
2016
Q4 | $1.36M | Sell |
23,223
-18,493
| -44% | -$1.01M | 0.37% | 71 |
|
|
2016
Q3 | $2.25M | Sell |
41,716
-7,506
| -15% | -$482K | 0.66% | 37 |
|
|
2016
Q2 | $3.62M | Sell |
49,222
-1,097
| -2% | -$77.5K | 1.13% | 22 |
|
|
2016
Q1 | $3.22M | Buy |
50,319
+1,709
| +4% | +$108K | 1.05% | 26 |
|
|
2015
Q4 | $3.35M | Buy |
48,610
+6,481
| +15% | +$428K | 1.14% | 22 |
|
|
2015
Q3 | $2.5M | Buy |
42,129
+148
| +0.4% | +$9.39K | 0.9% | 29 |
|
|
2015
Q2 | $2.79M | Buy |
41,981
+2,778
| +7% | +$183K | 0.93% | 24 |
|
|
2015
Q1 | $2.53M | Buy |
39,203
+11,382
| +41% | +$713K | 0.87% | 30 |
|
|
2014
Q4 | $1.65M | Buy |
27,821
+1,328
| +5% | +$74.9K | 0.6% | 42 |
|
|
2014
Q3 | $1.35M | Buy |
26,493
+3,432
| +15% | +$171K | 0.5% | 48 |
|
|
2014
Q2 | $1.12M | Buy |
23,061
+2,301
| +11% | +$113K | 0.4% | 63 |
|
|
2014
Q1 | $1.08M | Buy |
20,760
+6,099
| +42% | +$325K | 0.43% | 64 |
|
|
2013
Q4 | $782K | Buy |
14,661
+4,723
| +48% | +$241K | 0.32% | 84 |
|
|
2013
Q3 | $459K | Buy |
9,938
+2,036
| +26% | +$89.4K | 0.2% | 130 |
|
|
2013
Q2 | $351K | Buy |
+7,902
| New | +$343K | 0.17% | 151 |
|
Other funds holding BMY
Brown Advisory Securities's BMY Position: Q3 2022 in Review
Brown Advisory Securities sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 4,583 shares — an estimated $351K sold.
Brown Advisory Securities first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $3.62M in Q2 2016. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Brown Advisory Securities reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Brown Advisory Securities sold 4,583 Bristol-Myers Squibb shares in Q3 2022, an estimated $351K.
- Brown Advisory Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Brown Advisory Securities's Bristol-Myers Squibb position peaked at $3.62M in Q2 2016.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Brown Advisory Securities's 13F filing for Q3 2022, filed 14 Nov 2022.